[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 10 of about 411048
1. Szymała M, Streb W, Mitręga K, Podolecki T, Mencel G, Kukulski T, Kalarus Z: Percutaneous left atrial appendage occlusion procedures in patients with heart failure. Kardiol Pol; 2017;75(9):868-876
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Percutaneous left atrial appendage occlusion procedures in patients with heart failure.
  • Percutaneous left atrial appendage occlusion (LAAO) may be considered for stroke prophylaxis in patients with nonvalvular AF (NVAF), especially in contraindications for oral anticoagulants (OAC) or high risk of bleeding.
  • Moreover, there are no studies on patients with NVAF and heart failure with severe left ventricular systolic dysfunction (left ventricular ejection fraction [LVEF] ≤ 35%).
  • AIM: To assess the safety, efficacy, and mid-term outcomes of LAAO procedures with Amplatzer Cardiac Plug (ACP) and Amplatzer Amulet device in patients with NVAF and heart failure with LVEF ≤ 35% (group I) and to perform a comparative analysis of the patients who had LAAO with NVAF and LVEF > 35%.
  • METHODS: The analysis included 80 patients (group I: 19, group II: 61) with NVAF.
  • Serious periprocedural complications (cardiac tamponade: 2.5%, device embolisation: 1.25%, unexplained death: 1.25%) occurred only in patients from group II (p = NS).
  • During follow-up, one transient ischaemic attack and three deaths not related to the procedure occurred.
  • CONCLUSIONS: Percutaneous LAAO is an effective and safe procedure in patients with NVAF and severe systolic heart failure.
  • No significant periprocedural and mid-term differences, in terms of safety and efficacy, between the group with severe systolic heart failure (LVEF ≤ 35%) and the group without severe left ventricular systolic dysfunction (LVEF > 35%) were found.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28612910.001).
  • [ISSN] 1897-4279
  • [Journal-full-title] Kardiologia polska
  • [ISO-abbreviation] Kardiol Pol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Poland
  • [Keywords] NOTNLM ; atrial fibrillation / heart failure / left atrial appendage occlusion / stroke
  •  go-up   go-down


2. Rorabaugh BR, Seeley SL, Stoops TS, D'Souza MS: Repeated exposure to methamphetamine induces sex-dependent hypersensitivity to ischemic injury in the adult rat heart. PLoS One; 2017;12(6):e0179129
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Repeated exposure to methamphetamine induces sex-dependent hypersensitivity to ischemic injury in the adult rat heart.
  • BACKGROUND: We previously reported that adult female, but not male rats that were prenatally exposed to methamphetamine exhibit myocardial hypersensitivity to ischemic injury.
  • The goal of this study was to determine whether methamphetamine exposure during adulthood sensitizes the heart to ischemic injury.
  • METHODS: Adult male and female rats received daily injections of methamphetamine (5 mg/kg) or saline for 10 days.
  • Their hearts were isolated on day 11 and subjected to a 20 min ischemic insult on a Langendorff isolated heart apparatus.
  • Cardiac contractile function was measured by an intraventricular balloon, and infarct size was measured by triphenyltetrazolium chloride staining.
  • RESULTS: Hearts from methamphetamine-treated females exhibited significantly larger infarcts and suppressed postischemic recovery of contractile function compared to hearts from saline-treated females.
  • In contrast, methamphetamine had no effect on infarct size or contractile recovery in male hearts.
  • Subsequent experiments demonstrated that hypersensitivity to ischemic injury persisted in female hearts following a 1 month period of abstinence from methamphetamine.
  • Myocardial protein kinase C-ε expression, Akt phosphorylation, and ERK phosphorylation were unaffected by adult exposure to methamphetamine.
  • CONCLUSIONS: Exposure of adult rats to methamphetamine sex-dependently increases the extent of myocardial injury following an ischemic insult.
  • These data suggest that women who have a heart attack might be at risk of more extensive myocardial injury if they have a recent history of methamphetamine abuse.
  • [MeSH-major] Central Nervous System Stimulants / adverse effects. Heart / drug effects. Heart / physiopathology. Methamphetamine / adverse effects. Myocardial Infarction / etiology. Myocardial Ischemia / complications
  • [MeSH-minor] Animals. Female. Male. Myocardial Contraction / drug effects. Myocardium / pathology. Rats. Rats, Sprague-Dawley. Sex Factors

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cardiovasc Toxicol. 2017 Jan;17 (1):13-24 [27663745.001]
  • [Cites] J Physiol. 2005 Apr 15;564(Pt 2):619-30 [15718263.001]
  • [Cites] N Engl J Med. 1990 Oct 18;323(16):1147-8 [2215590.001]
  • [Cites] Heart Fail Rev. 2007 Dec;12(3-4):181-8 [17516169.001]
  • [Cites] Cardiovasc Res. 2010 Jul 1;87(1):111-8 [20139112.001]
  • [Cites] Behav Pharmacol. 2015 Dec;26(8 Spec No):786-97 [26536631.001]
  • [Cites] Am J Physiol. 1999 Nov;277(5 Pt 2):H1754-61 [10564128.001]
  • [Cites] Dev Psychobiol. 2007 Apr;49(3):312-22 [17380528.001]
  • [Cites] Basic Res Cardiol. 2003 Sep;98(5):337-46 [12955407.001]
  • [Cites] Toxicol Appl Pharmacol. 2005 Dec 15;209(3):203-13 [15916788.001]
  • [Cites] J Mol Cell Cardiol. 2009 Oct;47(4):504-11 [19538969.001]
  • [Cites] Toxicol Appl Pharmacol. 2016 Mar 15;295:1-11 [26825372.001]
  • [Cites] Front Psychiatry. 2015 Jul 06;6:91 [26217239.001]
  • [Cites] Drug Alcohol Depend. 2007 Jan 12;86(2-3):183-90 [16884865.001]
  • [Cites] Am J Health Syst Pharm. 1997 Mar 1;54(5):586-7 [9066872.001]
  • [Cites] Brain Res. 1995 Sep 18;692(1-2):269-72 [8548314.001]
  • [Cites] J Pharmacol Exp Ther. 2017 Mar;360(3):409-416 [28035008.001]
  • [Cites] PLoS One. 2015 Oct 20;10(10):e0139829 [26484527.001]
  • [Cites] Neurocrit Care. 2009;10(3):295-305 [19132558.001]
  • [Cites] Drug Discov Today. 2011 Dec;16(23-24):1007-18 [21945859.001]
  • [Cites] Neuroscience. 2000;95(4):1061-70 [10682713.001]
  • [Cites] Drug Alcohol Depend. 2014 Jun 1;139:138-44 [24726427.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H505-15 [26702143.001]
  • [Cites] Psychopharmacology (Berl). 2004 Apr;172(4):443-9 [14654996.001]
  • [Cites] Circ J. 2010 Apr;74(4):634-43 [20173305.001]
  • [Cites] J Invasive Cardiol. 2007 Apr;19(4):E89-92 [17404411.001]
  • [Cites] J Pharmacol Exp Ther. 2009 Aug;330(2):624-32 [19470841.001]
  • [Cites] Neurochem Res. 2016 Aug;41(8):1911-23 [27038442.001]
  • [Cites] Eur J Pharmacol. 2002 May 10;442(3):231-5 [12065076.001]
  • [Cites] Am J Cardiol. 2016 Aug 15;118(4):585-9 [27374605.001]
  • [Cites] Mol Med Rep. 2014 Nov;10(5):2306-12 [25230843.001]
  • [Cites] J Clin Psychiatry. 2016 Oct;77(10 ):1396-1403 [27574836.001]
  • [Cites] Metab Brain Dis. 2016 Aug;31(4):975-81 [27021292.001]
  • [Cites] Addiction. 2007 Apr;102 Suppl 1:70-5 [17493055.001]
  • [Cites] Circ Res. 2010 Aug 6;107(3):365-73 [20538683.001]
  • [Cites] Behav Brain Res. 2017 Jun 1;327:94-97 [28359885.001]
  • [Cites] J Addict Med. 2014 May-Jun;8(3):183-8 [24695019.001]
  • [Cites] Mol Cell Biochem. 2016 Jan;412(1-2):147-54 [26715132.001]
  • [Cites] Eur J Nucl Med. 2000 Jul;27(7):867-9 [10952500.001]
  • [Cites] Cardiovasc Res. 2011 Jan 1;89(1):89-97 [20733009.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H971-6 [15358610.001]
  • [Cites] Drug Alcohol Depend. 2006 Dec 1;85(3):198-204 [16723192.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H516-23 [26683901.001]
  • [Cites] J Am Dent Assoc. 2008 Feb;139(2):171-6 [18245685.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2644-47 [16473955.001]
  • [Cites] Naunyn Schmiedebergs Arch Pharmacol. 2014 Jan;387(1):47-58 [24062016.001]
  • [Cites] Psychopharmacology (Berl). 2015 Jun;232(12):2083-95 [25572530.001]
  • [Cites] Br J Pharmacol. 2009 Jul;157(5):705-15 [19422373.001]
  • [Cites] Am J Physiol. 1998 Aug;275(2 Pt 2):H495-500 [9683437.001]
  • [Cites] Cardiovasc Res. 2007 Jan 1;73(1):153-63 [17126307.001]
  • [Cites] Synapse. 2013 May;67(5):245-57 [23280858.001]
  • [Cites] J Mol Cell Cardiol. 2015 Jan;78:142-53 [25172387.001]
  • [Cites] Am J Emerg Med. 2006 Jan;24(1):132-4 [16338525.001]
  • [Cites] J Pharmacol Exp Ther. 2008 Jan;324(1):331-41 [17947495.001]
  • [Cites] Biol Reprod. 2009 Mar;80(3):440-8 [18945988.001]
  • (PMID = 28575091.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Central Nervous System Stimulants; 44RAL3456C / Methamphetamine
  •  go-up   go-down


3. Goldberg RJ, Gore JM, Alpert JS, Dalen JE: Therapeutic trends in the management of patients with acute myocardial infarction (1975-1984): the Worcester Heart Attack Study. Clin Cardiol; 1987 Jan;10(1):3-8
Hazardous Substances Data Bank. DIGOXIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Therapeutic trends in the management of patients with acute myocardial infarction (1975-1984): the Worcester Heart Attack Study.
  • As part of an ongoing community-wide study of time trends in the incidence and case-fatality rates of patients hospitalized with acute myocardial infarction (MI) in all 16 Worcester, Massachusetts, metropolitan hospitals during the years 1975, 1978, 1981, and 1984, changes over time in the therapeutic management of 3263 patients with validated acute myocardial infarction were examined.
  • Lidocaine use increased between 1975 (31%) and 1978 (52%) and then leveled off to being used in approximately 45% of hospitalized patients with acute MI in 1981 and 1984.
  • A variety of demographic (e.g., age, sex, teaching hospital) and clinical characteristics (e.g., MI order, MI type, MI location, peak CPK findings, occurrence of acute clinical complications) were also associated with the use of these therapies for the combined study periods.
  • The results of this population-based study suggest considerable changes over time in the therapeutic management of patients hospitalized with acute myocardial infarction and of numerous patient demographic and clinical factors associated with their use.
  • [MeSH-major] Myocardial Infarction / drug therapy

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. LIDOCAINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 2880685.001).
  • [ISSN] 0160-9289
  • [Journal-full-title] Clinical cardiology
  • [ISO-abbreviation] Clin Cardiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Adrenergic beta-Antagonists; 0 / Anti-Arrhythmia Agents; 0 / Nitrates; 73K4184T59 / Digoxin; 98PI200987 / Lidocaine
  •  go-up   go-down


Advertisement
4. Patel MD, Wu D, Chase MR, Mavros P, Heithoff K, Hanson ME, Simpson RJ Jr: Antiplatelet Therapy and Clinical Outcomes Following Myocardial Infarction Among Patients in a U.S. Employer-Based Insurance Database. J Manag Care Spec Pharm; 2017 Jun;23(6):684-690

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Antiplatelet Therapy and Clinical Outcomes Following Myocardial Infarction Among Patients in a U.S. Employer-Based Insurance Database.
  • BACKGROUND: Estimates of residual cardiovascular risks among patients who have experienced a recent acute myocardial infarction (MI) are predominantly derived from secondary prevention trial populations, patient registries, and population-based cohorts.
  • OBJECTIVE: To generate real-world evidence of antiplatelet treatment and recurrent events following MI in patients on antiplatelet treatment among commercial, employer-based insured patients in a large administrative database.
  • METHODS: This was a retrospective cohort claims database study using the Truven Health MarketScan Commercial Claims and Encounters and Medicare Supplemental databases between 2007-2011.
  • Patients with an acute MI hospitalization with a discharge date between 2008 and 2010 were included.
  • Excluded were those patients with documentation of stroke, transient ischemic attack (TIA), or severe bleeding at or before index hospitalization and with concomitant use of anticoagulant therapy following index hospitalization.
  • Patients treated with clopidogrel following the index MI hospitalization were followed up to 1 year for repeat MI, stroke, and coronary revascularization.
  • RESULTS: Among 33,943 post-MI continuous clopidogrel users without history of stroke, TIA, or bleeding, 22% had diabetes, whereas angina and renal impairment were less prevalent (5% and 7%, respectively).
  • Over the 1-year follow-up, 2.4% experienced a repeat MI or stroke, and 8.2% underwent coronary revascularization.
  • Angina, diabetes, and renal impairment were associated with elevated 1-year risk of repeat MI or stroke.
  • CONCLUSIONS: This study suggests that there is residual cardiovascular risk, although relatively low, in an insured, secondary prevention population on antiplatelet treatment following an MI.
  • In patients with MI, identifying angina, diabetes, and renal impairment may aid risk stratification and guide the effective management of these higher-risk patients.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28530518.001).
  • [ISSN] 2376-1032
  • [Journal-full-title] Journal of managed care & specialty pharmacy
  • [ISO-abbreviation] J Manag Care Spec Pharm
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Quah JL, Yap S, Cheah SO, Ng YY, Goh ES, Doctor N, Leong BS, Tiah L, Chia MY, Ong ME: Knowledge of signs and symptoms of heart attack and stroke among Singapore residents. Biomed Res Int; 2014;2014:572425
MedlinePlus Health Information. consumer health - Stroke.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Knowledge of signs and symptoms of heart attack and stroke among Singapore residents.
  • AIM: To determine the level of knowledge of signs and symptoms of heart attack and stroke in Singapore resident population, in comparison to the global community.
  • METHODS: A population based, random sample of 7,840 household addresses was selected from a validated national sampling frame.
  • Each participant was asked eight questions on signs and symptoms of heart attack and 10 questions on stroke.
  • The level of knowledge for preselected, common signs and symptoms of heart attack and stroke was 57.8% and 57.1%, respectively.
  • The respondents scored a mean of 5.0 (SD 2.4) out of 8 for heart attack, while they scored a mean of 6.8 (SD 2.9) out of 10 for stroke.
  • The level of knowledge of signs and symptoms of heart attack and stroke in Singapore is comparable to USA and Canada.
  • CONCLUSION: We found a comparable knowledge of stroke and heart attack signs and symptoms in the community to countries within the same economic, educational, and healthcare strata.
  • [MeSH-major] Health Knowledge, Attitudes, Practice. Heart Failure / epidemiology. Stroke / epidemiology
  • [MeSH-minor] Adult. Data Collection. Demography. Female. Humans. Logistic Models. Middle Aged. Risk Factors. Singapore / epidemiology

  • MedlinePlus Health Information. consumer health - Heart Failure.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 1995 Dec 14;333(24):1581-7 [7477192.001]
  • [Cites] Ann Emerg Med. 1994 Feb;23(2):311-29 [8304613.001]
  • [Cites] Intern Med J. 2005 May;35(5):279-82 [15845109.001]
  • [Cites] Am Heart J. 2005 Sep;150(3):392-400 [16169313.001]
  • [Cites] Stroke. 2006 May;37(5):1248-53 [16556885.001]
  • [Cites] PLoS Med. 2006 Nov;3(11):e442 [17132052.001]
  • [Cites] JAMA. 2010 Apr 14;303(14):1392-400 [20388895.001]
  • [Cites] Eur J Emerg Med. 2011 Oct;18(5):268-71 [21317785.001]
  • [Cites] BMC Public Health. 2012;12:283 [22490185.001]
  • [Cites] Heart. 2000 Apr;83(4):388-93 [10722534.001]
  • [Cites] JAMA. 2000 Jun 28;283(24):3223-9 [10866870.001]
  • [Cites] BMC Public Health. 2001;1:14 [11734071.001]
  • [Cites] Neurology. 2002 Nov 26;59(10):1547-52 [12451195.001]
  • [Cites] Emerg Med (Fremantle). 2002 Sep;14(3):255-60 [12487042.001]
  • [Cites] JAMA. 2003 Jan 15;289(3):343-6 [12525235.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2004 May 7;53(17):359-62 [15129192.001]
  • [Cites] Circulation. 1990 Aug;82(2):664-707 [2197021.001]
  • [Cites] Arch Intern Med. 1993 Nov 22;153(22):2558-61 [7598755.001]
  • [Cites] Med J Aust. 1997 Mar 3;166(5):233-6 [9076265.001]
  • (PMID = 24812623.001).
  • [ISSN] 2314-6141
  • [Journal-full-title] BioMed research international
  • [ISO-abbreviation] Biomed Res Int
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC4000924
  •  go-up   go-down


6. Bahr RD: The EHAC (early heart attack care) strategy: Citizens Chart the Course for Healthy People in the Year 2000. J Cardiovasc Manag; 1995 May-Jun;6(3):19-23
MedlinePlus Health Information. consumer health - Heart Attack.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The EHAC (early heart attack care) strategy: Citizens Chart the Course for Healthy People in the Year 2000.
  • Within the last four years, more than 500 chest pain centers have developed in response to new paradigms for early heart attack care.
  • These shifting paradigms now focus on acute prevention, in terms of both early thrombolytic therapy and cardioprotection of patients with prodromal symptoms of a heart attack.
  • [MeSH-major] Cardiology Service, Hospital. Health Promotion / trends. Myocardial Infarction / therapy
  • [MeSH-minor] Cardiopulmonary Resuscitation. Chest Pain / diagnosis. Health Education. Humans. Pain Clinics. Thrombolytic Therapy / trends. United States

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10143350.001).
  • [ISSN] 1053-5330
  • [Journal-full-title] The Journal of cardiovascular management : the official journal of the American College of Cardiovascular Administrators
  • [ISO-abbreviation] J Cardiovasc Manag
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  •  go-up   go-down


7. Traffic noise increases the risk of heart attack in men. Nurs Stand; 2005 Mar 02;19(25):10

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Traffic noise increases the risk of heart attack in men.
  • : Chronic exposure to high levels of traffic noise increases the risk for cardiovascular diseases in men but not in women.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28055466.001).
  • [ISSN] 2047-9018
  • [Journal-full-title] Nursing standard (Royal College of Nursing (Great Britain) : 1987)
  • [ISO-abbreviation] Nurs Stand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


9. Goldberg RJ, Gore JM, Alpert JS, Dalen JE: Incidence and case fatality rates of acute myocardial infarction (1975-1984): the Worcester Heart Attack Study. Am Heart J; 1988 Apr;115(4):761-7
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidence and case fatality rates of acute myocardial infarction (1975-1984): the Worcester Heart Attack Study.
  • During the calendar years 1975, 1978, 1981, and 1984, a community-wide study in the Worcester, Massachusetts, metropolitan area has examined time trends in the attack and case fatality rates of acute myocardial infarction (MI) as well as the occurrence of out-of-hospital coronary heart disease deaths.
  • Between 1975 and 1981, there was a slight increase in the age-adjusted attack rates of acute MI; between 1981 and 1984, however, there was a dramatic decline in the incidence rates of acute MI.
  • These temporal trends over the 10-year period examined resulted in an overall decrease in both the incidence rates of initial (255 per 100,000-1975; 186 per 100,000-1984) as well as recurrent (133 per 100,000-1975; 104 per 100,000-1984) acute MI in the 16 hospitals surveyed.
  • The age-adjusted in-hospital case fatality rates of acute MI declined consistently over the periods studied, from 22.2% in 1975 to 20.3% in 1978, 17.8% in 1981, and to 15.1% in 1984, for an overall decline of 32% over the 10-year period studied.
  • No significant differences, however, were seen in the long-term survival rates of patients discharged from the hospital after acute MI in either 1975, 1978, 1981, or 1984.
  • A consistent decline was seen in the age-adjusted mortality rates (per 100,000) of out-of-hospital coronary heart disease between 1975 (265), 1978 (174), 1981 (170), and 1984 (148).(ABSTRACT TRUNCATED AT 250 WORDS)
  • [MeSH-major] Myocardial Infarction / epidemiology
  • [MeSH-minor] Adult. Coronary Disease / mortality. Female. Hospitalization. Humans. Male. Massachusetts. Middle Aged

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 3354404.001).
  • [ISSN] 0002-8703
  • [Journal-full-title] American heart journal
  • [ISO-abbreviation] Am. Heart J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  •  go-up   go-down


10. Goldberg RJ, Ockene IS, Yarzebski J, Savageau J, Gore JM: Use of lipid-lowering medication in patients with acute myocardial infarction (Worcester Heart Attack Study). Am J Cardiol; 1997 Apr 15;79(8):1095-7
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Use of lipid-lowering medication in patients with acute myocardial infarction (Worcester Heart Attack Study).
  • As part of a population-based longitudinal study, we examined the use of lipid-lowering medication in 3,824 patients hospitalized with acute myocardial infarction in the Worcester, Massachusetts metropolitan area between 1986 and 1993.
  • The rate of utilization of lipid-lowering medication either before (1.8%) or during hospitalization (1.9%) for acute myocardial infarction was low.
  • [MeSH-major] Hyperlipidemias / drug therapy. Hypolipidemic Agents / therapeutic use. Myocardial Infarction / etiology
  • [MeSH-minor] Coronary Disease / drug therapy. Hospitalization. Humans. Logistic Models. Odds Ratio. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 9114770.001).
  • [ISSN] 0002-9149
  • [Journal-full-title] The American journal of cardiology
  • [ISO-abbreviation] Am. J. Cardiol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Hypolipidemic Agents
  •  go-up   go-down






Advertisement